(Q38351525)

2 September 2017

Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production (English)

1 reference

2 September 2017

1 reference

Dongxu Sun

1

1 reference

PubMed ID

12914758

2 September 2017

Gabriel Fernandes

series ordinal

2

1 reference

PubMed ID

12914758

2 September 2017

language of work or name

1 reference

1 May 2003

1 reference

2 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Cellular Immunology

1 reference

2 September 2017

223

1 reference

2 September 2017

1

1 reference

2 September 2017

52-62

1 reference

Current perspectives on statins

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Statins as a newly recognized type of immunomodulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Effect of pravastatin on outcomes after cardiac transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Origin, maturation and antigen presenting function of dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Cell cycle-specific effects of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Maintenance of NF-kappaB activation in T-lymphocytes and a naive T-cell population in autoimmune-prone (NZB/NZW)F(1) mice by feeding a food-restricted diet enriched with n-3 fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Identifying strategies for immune intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Expression of relB is required for the development of thymic medulla and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Dendritic cell survival and maturation are regulated by different signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Cytokine modulation of LDL oxidation by activated human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Effects of an HMG-CoA reductase inhibitor on cytokine production by human monocytes/macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF-alpha activated human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Stimulation of bone formation in vitro and in rodents by statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Simvastatin-induced lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lupuslike syndrome associated with simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Lovastatin-induced lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

Simvastatin initiated early after heart transplantation: 8-year prospective experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900148-5

10.1016/S0008-8749(03)00148-5

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

12914758